(Q43810329)

27 November 2017

title

Intellectual property, drug licensing, freedom of information, and public health (English)

1 reference

27 November 2017

0 references

intellectual property

0 references

author name string

I Roberts

series ordinal

1

1 reference

27 November 2017

A L Po

series ordinal

2

1 reference

27 November 2017

I Chalmers

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

27 November 2017

1 reference

27 November 2017

volume

352

1 reference

27 November 2017

issue

9129

1 reference

27 November 2017

page(s)

726-729

1 reference

Secrecy in drug regulationLicensing documentation on the Norplant® contraceptive.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907600-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907600-4

1 reference

7 January 2021

Study of information submitted by drug companies to licensing authorities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907600-4

7 January 2021

Effect of albumin supplementation during parenteral nutrition on hospital morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907600-4

7 January 2021

Ethical imperative to publish extends to academics too.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907600-4

7 January 2021

Meeting the challenges facing research ethics committees: some practical suggestions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907600-4

7 January 2021

10.1016/S0140-6736(98)07600-4

Identifiers

DOI

1 reference

27 November 2017

1 reference